Wells Fargo & Company Ark Genomic Revolution ETF (De Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Wells Fargo & Company holds 1,288,225 shares of ARKG stock, worth $30 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,288,225

Previous 1,291,740 0.27%

Holding current value

$30 Million

Previous $30.3 Million 8.73%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$22.89 - $27.41 $80,458 - $96,346	-3,515 Reduced 0.27%	1,288,225 $33 Million
Q2 2024 Aug 13, 2024	SELL	$23.01 - $28.35 $265,972 - $327,697	-11,559 Reduced 0.89%	1,291,740 $30.3 Million
Q1 2024 May 10, 2024	BUY	$27.9 - $32.96 $14.7 Million - $17.4 Million	527,894 Added 68.08%	1,303,299 $37.5 Million
Q4 2023 Feb 09, 2024	SELL	$22.24 - $34.25 $11.1 Million - $17.1 Million	-498,364 Reduced 39.13%	775,405 $25.4 Million
Q3 2023 Nov 13, 2023	SELL	$27.6 - $38.18 $40.8 Million - $56.5 Million	-1,478,845 Reduced 53.73%	1,273,769 $35.5 Million
Q2 2023 Aug 15, 2023	BUY	$28.26 - $35.21 $7.85 Million - $9.78 Million	277,885 Added 11.23%	2,752,614 $93.8 Million
Q1 2023 May 12, 2023	BUY	$27.46 - $36.49 $5.53 Million - $7.34 Million	201,263 Added 8.85%	2,474,729 $74.4 Million
Q4 2022 Feb 13, 2023	BUY	$27.08 - $36.23 $32.1 Million - $43 Million	1,185,513 Added 108.97%	2,273,466 $64.2 Million
Q3 2022 Nov 14, 2022	BUY	$31.57 - $42.39 $2.9 Million - $3.89 Million	91,712 Added 9.21%	1,087,953 $35.8 Million
Q2 2022 Aug 12, 2022	SELL	$27.2 - $48.94 $505,430 - $909,403	-18,582 Reduced 1.83%	996,241 $31.4 Million
Q1 2022 May 16, 2022	SELL	$38.15 - $63.26 $2.86 Million - $4.74 Million	-74,990 Reduced 6.88%	1,014,823 $46.6 Million
Q4 2021 Feb 14, 2022	BUY	$58.39 - $78.64 $16.4 Million - $22.1 Million	280,528 Added 34.66%	1,089,813 $66.7 Million
Q3 2021 Nov 15, 2021	SELL	$73.87 - $92.86 $1.16 Million - $1.46 Million	-15,756 Reduced 1.91%	809,285 $60.5 Million
Q2 2021 Aug 16, 2021	SELL	$73.64 - $93.1 $13.7 Million - $17.4 Million	-186,668 Reduced 18.45%	825,041 $76.3 Million
Q1 2021 May 13, 2021	BUY	$81.74 - $112.47 $32.4 Million - $44.6 Million	396,519 Added 64.45%	1,011,709 $89.8 Million
Q4 2020 Feb 09, 2021	BUY	$63.39 - $105.53 $11.3 Million - $18.7 Million	177,673 Added 40.61%	615,190 $57.4 Million
Q3 2020 Nov 05, 2020	BUY	$53.19 - $64.24 $3.25 Million - $3.93 Million	61,151 Added 16.25%	437,517 $27.9 Million
Q2 2020 Aug 13, 2020	BUY	$29.13 - $53.08 $1.55 Million - $2.83 Million	53,259 Added 16.48%	376,366 $19.6 Million
Q1 2020 May 14, 2020	BUY	$24.5 - $37.69 $7.92 Million - $12.2 Million	323,107 New	323,107 $10.1 Million

Others Institutions Holding ARKG

# of Institutions

287

Shares Held

24.5M

Call Options Held

3.02M

Put Options Held

2.65M

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ark Genomic Revolution ETF (De Transaction History